APP and Alzheimer disease: It is unclear how APP affects the ischemic environment, or how the lack of APP leads to acute mortality, but these observations may have implications in AD patients treated with Aβ and APP targeted therapies as strokes and ischemic episodes are frequent in the elderly population.